跳至主要内容
临床试验/CTRI/2026/03/106006
CTRI/2026/03/106006尚未招募Phase 3 4

Comparison of Levobupivacaine and Ropivacaine on Diaphragmatic function in patients undergoing Forearm surgeries under ultrasound guided Supraclavicular Brachial Plexus Block - a randomised control trial

Vemulapalli Meghana1 个研究点 分布在 1 个国家目标入组 182 人开始时间: 2026年4月1日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
182
试验地点
1

研究概览

简要总结

Ropivacaine and Levobupivacaine are two commonly used local anaesthetics in supraclavicular block for forearm surgeries. Various complications can occur with supraclavicular block like hemidiaphragmatic paralysis (HDP) which is usually asymptomatic in healthy individuals but severe complications exists in patients with respiratory compromise. Various other complications can also be associated with supraclaviclavicular block.

The study compares the incidence of HDP in patients who will be given Levobupivacaine vs ropivacaine under ultrasound guidance supraclavicular brachial plexus block in forearm surgeries.

A total sample size of 182 patients will be selected based upon the inclusion and exclusion criteria and will be randomly divided into 2 groups with each group consisting of 91 patients.

Baseline assessment will be done followed by post block assessment for diaphragmatic paralysis at 15 mins, 30 mins and 2 hours and patients shall be assessed whether they are asymptomatic or symptomatic.

NRS score of the patients will be taken post operatively at 6 hours, 12 hours and 24 hours to assess for pain. Rescue analgesia shall be provided to the patient as needed.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 64.00 Year(s)(—)
性别
All

入选标准

  • ASA Grade 1 and 2 2) Forearm Surgeries.

排除标准

  • Patient refusal 2) Local infection 3) Bleeding disorders 4) Coagulopathies 5) Allergic to local anesthetic agent 6) Patients with neuromuscular disorders and weakness and hemidiaphragmatic dysfunction 7) Patients with pre-existing cardiac and lung pathologies 8) Pregnancy.

研究者

发起方
Vemulapalli Meghana
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Vemulapalli Meghana

Nizam’s Institute of Medical Sciences

研究点 (1)

Loading locations...

相似试验